The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post “for a period to support a smooth transition to new leadership.”
Novo Nordisk CEO to step down as competition weighs on Wegovy maker’s share price
Related Posts
Europe must be prepared for Trump tariffs, European Central Bank chief warns
European Central Bank President Christine Lagarde spoke to CNBC at the World Economic Forum in Davos.
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing,…
Unveiling Attention Sinks: The Functional Role of First-Token Focus in Stabilizing Large Language Models
LLMs often show a peculiar behavior where the first token in a sequence draws unusually high attention—known as an “attention…